Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to the need for ongoing management of patients on GLP-1s, an obesity expert says.
Research symposia focus on new combinations and medication formulations for both obesity and type 2 diabetes, as well as new approaches for type 1 diabetes…
Here’s how to coach your patients with obesity to healthier hearts.
Many Medicare Advantage plans are not delivering better, more efficient care than traditional Medicare, and they need more oversight and accountability, Madelaine A. Feldman, MD,…
Transforming Gastric and GEJ Cancer Care With Perioperative Immunotherapy: Latest Updates From Chicago
An international expert panel has developed the first consensus-based framework for reporting ‘set and setting’ variables in psychedelic clinical trials.
Join us in for the 26th annual Las Vegas Dermatology seminar for the latest advancements in psoriasis, acne management and treatment, rosacea, cutaneous malignancies, and…
A study using data from a European registry shows cashew as the most frequent elicitor of tree nut-induced anaphylaxis in children.
Understanding which patients are less likely to respond to first-line therapy may help clinicians arrive at an effective treatment sooner.
Cannabis users have significantly higher risks for dying from cardiovascular disease, according to a sweeping new study, prompting experts to call for tobacco-style regulation.
Naval Daver, MD, a hematologist-oncologist who has led more than 100 clinical trials, predicts the next 5 years will see successful development of cellular therapies…
